Author:
Dashiell-Aje Ebony,Harding Gale,Pascoe Katie,DeVries Jane,Berry Pamela,Ramachandran Sulabha
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. GlaxoSmithKline. Benlysta Prescribing Information. Rockville: GlaxoSmithKline; 2017. hhttps://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Benlysta/pdf/BENLYSTA-PI-MG-IFU-COMBINED.PDF . Accessed 22 Sept 2017.
2. Pascoe K, Lobosco S, Bell D, Hoskin B, Ramachandran S, Pobiner B, et al. Patient- and physician-reported satisfaction with systemic lupus erythematosus treatment in US clinical practice. Clin Ther. (Epub 10 August 2017).
3. Ridyard CH, Dawoud DMM, Tuersley LV, Hughes DA. A systematic review of patients’ perspectives on the subcutaneous route of medication administration. Patient. 2016;9(4):281–92.
4. Struemper H, Murtaugh T, Gilbert J, Barton ME, Fire J, Groark J, et al. The relative bioavailability of a single dose of belimumab administered subcutaneously by prefilled syringe or autoinjector in healthy subjects. Clin Pharmacol Drug Dev. 2016;5(3):208–15.
5. Sheikh SZ, Hammer AE, Fox NL, Groark J, Struemper H, Roth D, et al. Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus. Int J Pharmacol Ther. 2016;54(11):914–22.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献